Loading data
SYRENasdaq
| Unit: USD | FY2025 | FY2024 | FY2023 | FY2022 | FY2021 |
|---|---|---|---|---|---|
| Revenue | 0 USD | 0 USD | 886 k USD | 2.33 m USD | 18.74 m USD |
| Research and development expense | — | — | — | 58.58 m USD | 57.07 m USD |
| Operating profit | -209.56 m USD | -208.57 m USD | -242.3 m USD | -84.78 m USD | -65.65 m USD |
| Profit before tax | -155.22 m USD | -207.97 m USD | -338.82 m USD | -83.95 m USD | -65.66 m USD |
| Income tax expense | -15 k USD | 51 k USD | -26 k USD | -136 k USD | 141 k USD |
| Net income (reported basis) | -155.2 m USD | -208.02 m USD | -338.79 m USD | -83.82 m USD | -65.8 m USD |
| Basic earnings per share | — | — | 13.76 USD/share | -24.86 USD/share | -25.02 USD/share |
| Diluted earnings per share | — | — | 13.76 USD/share | -24.86 USD/share | -25.02 USD/share |
Quotes are end-of-day data. Content is for research purposes and is not investment advice.